🇺🇸 FDA
Pipeline program

Zimberelimab

2000028799

Phase 1 small_molecule active

Quick answer

Zimberelimab for Glioblastoma is a Phase 1 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Arcus Biosciences
Indication
Glioblastoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials